Cellulitis
☆ I le 2022 Stiftung Warentest i'uga mai Siamani, o le fa'amalieina o tagata fa'atau i ModelDerm sa na'o sina maualalo ifo nai lo fa'atalanoaga telemedicine totogi.
O le vae o le nofoaga masani mo Cellulitis.
Tulaga masani
Vaega o faamalologa.
References
Cellulitis ose fa'ama'i pipisi masani ole pa'u. E aafia ai le silia ma le 14 miliona tagata i tausaga taʻitasi i le Iunaite Setete. E oʻo atu i le $ 3. 7 piliona i le tausiga o falemaʻi ma le 650,000 falemaʻi i tausaga taʻitasi. E masani lava, o le cellulitis e aliali mai o se vaega mafanafana, mumu i luga o le paʻu ma fula ma agavaivai. E afua mai i se fa'ama'i fa'afuase'i fa'ama'i e fa'atupu ai le fula i totonu o le pa'u loloto ma aano o lo'o lata ane. E leai se fa'ama'i po'o se na'o i lenei fa'ama'i. Beta-hemolytic streptococci, aemaise le vaega A streptococcus (Streptococcus pyogenes) , o mea masani ia, sosoo ai ma le methicillin-sensitive Staphylococcus aureus.
Cellulitis is a common bacterial skin infection, with over 14 million cases occurring in the United States annually. It accounts for approximately 3.7 billion dollars in ambulatory care costs and 650000 hospitalizations annually. Cellulitis typically presents as a poorly demarcated, warm, erythematous area with associated edema and tenderness to palpation. It is an acute bacterial infection causing inflammation of the deep dermis and surrounding subcutaneous tissue. The infection is without an abscess or purulent discharge. Beta-hemolytic streptococci typically cause cellulitis, generally group A streptococcus (i.e., Streptococcus pyogenes), followed by methicillin-sensitive Staphylococcus aureus. Patients who are immunocompromised, colonized with methicillin-resistant Staphylococcus aureus, bitten by animals, or have comorbidities such as diabetes mellitus may become infected with other bacteria.
Cellulitis is a common bacterial skin infection, with over 14 million cases occurring in the United States annually. It accounts for approximately 3.7 billion dollars in ambulatory care costs and 650000 hospitalizations annually. Cellulitis typically presents as a poorly demarcated, warm, erythematous area with associated edema and tenderness to palpation. It is an acute bacterial infection causing inflammation of the deep dermis and surrounding subcutaneous tissue. The infection is without an abscess or purulent discharge. Beta-hemolytic streptococci typically cause cellulitis, generally group A streptococcus (i.e., Streptococcus pyogenes), followed by methicillin-sensitive Staphylococcus aureus. Patients who are immunocompromised, colonized with methicillin-resistant Staphylococcus aureus, bitten by animals, or have comorbidities such as diabetes mellitus may become infected with other bacteria.
Cellulitis o se fa'ama'i pipisi o le pa'u ma a'ano vaivai. E tupu pe a iai ni fa'afitauli i le pa puipui o le pa'u, le puipuiga o le tino, po'o le tafe toto. Ma'i suka, puta, ma le matua e fa'atuputeleina le avanoa e maua ai cellulitis e ala i le a'afiaina o vaega nei. Matou te vaʻavaʻai foʻi i suʻesuʻega talu ai nei i le suʻesuʻeina o cellulitis , faʻamaonia le taua o le faʻamaonia saʻo talu ai tulaga e pei ole venous insufficiency, eczema, deep vein thrombosis, ma gout e masani ona fenumiai ma cellulitis. O vailaau fa'ama'i fa'aaoga e togafitia ai cellulitis e filifilia ma le fa'aeteete e fa'atatau i siama masani e aunoa ma le fa'amalosia o le tete'e atu i vaila'au. Matou te talanoa foi e uiga i vailaau fa'ama'i fou ua fa'amaonia mo cellulitis. Cellulitis e masani ona toe foʻi mai ona o aʻafiaga faifaipea ma faʻaleagaina le lymphatic system.
Cellulitis is a bacterial infection of the skin and soft tissues. It happens when there are issues with the skin's protective barrier, the immune system, or blood circulation. Diabetes, obesity, and old age increase the chances of cellulitis by affecting these areas. We also look at recent findings on diagnosing cellulitis, highlighting the importance of accurate diagnosis since conditions like venous insufficiency, eczema, deep vein thrombosis, and gout are often confused with cellulitis. Antibiotics used to treat cellulitis are chosen carefully to target common bacteria without encouraging antibiotic resistance. We also talk about new antibiotics approved for cellulitis. Cellulitis often comes back because of ongoing risk factors and damage to the lymphatic system..
Cellulitis is a bacterial infection of the skin and soft tissues. It happens when there are issues with the skin's protective barrier, the immune system, or blood circulation. Diabetes, obesity, and old age increase the chances of cellulitis by affecting these areas. We also look at recent findings on diagnosing cellulitis, highlighting the importance of accurate diagnosis since conditions like venous insufficiency, eczema, deep vein thrombosis, and gout are often confused with cellulitis. Antibiotics used to treat cellulitis are chosen carefully to target common bacteria without encouraging antibiotic resistance. We also talk about new antibiotics approved for cellulitis. Cellulitis often comes back because of ongoing risk factors and damage to the lymphatic system..
E to'atele tagata e o i falema'i po'o potu fa'afuase'i mo fa'ama'i fa'afuase'i o pa'u siama. Staphylococcus aureus o le siama autu lea e mafua ai nei faʻamaʻi, ma ua amata ona faigata ona togafitia ona o nisi faʻamaʻi e teteʻe i vailaʻau masani.
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
Staphylococcus aureus e mafai ona vaevaeina i ni ituaiga se lua e fua i le latou tali atu i vailaau fa'ama'i: methicillin-sensitive Staphylococcus aureus (MSSA) , methicillin-resistant Staphylococcus aureus (MRSA) . I nai tausaga ua tuana'i, ona o le evolusione siama ma le fa'aaogaina tele o vaila'au fa'ama'i, ua fa'atupula'ia le tete'e o S. Aureus i vaila'au, ma o'o atu ai i le si'itia i le lalolagi atoa i MRSA fua faatatau o fa'ama'i.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
To review the salient features of the management of severe skin and soft tissue infections (SSTIs), including toxic shock syndrome, myonecrosis/gas gangrene, and necrotizing fasciitis.
O vae ma foliga o nofoaga sili ona taatele e aofia ai. O tulaga lamatia e aofia ai le puta, fula o vae, ma le matua. Ole siama e masani ona a'afia ole streptococci ma Staphylococcus aureus.
Togafitiga e masani lava ile vaila'au e inu ile gutu, pei ole cephalexin, amoxicillin po'o le cloxacillin. E tusa ma le 95% o tagata e sili atu pe a uma le 7 i le 10 aso o togafitiga. Ae ui i lea, oi latou e maua i le ma'i suka, e masani lava ona sili atu ona leaga taunuuga.
O le Cellulitis o se faʻafitauli masani, ma i totonu o Peretania, o le cellulitis o le mafuaʻaga lea mo le 1.6% o le ulufale i le falemaʻi. Cellulitis i le 2015 na mafua ai le tusa ma le 16,900 maliu i le lalolagi atoa.
○ Togafitiga - Vailaau OTC
Ole cellulitis maualuga e manaʻomia togafitiga ile vailaʻau faʻamaʻi e faʻatonuina e se fomaʻi. Afai e saosaoa le alualu i luma o le manu'a ma o mai faatasi ma le fiva ma le malulu, e fautuaina e vaai se foma'i i se taimi vave e mafai ai.
E mafai ona fesoasoani le fa'aogaina o se suau'u fa'ama'i fa'ama'i fa'ato'a fa'atau atu i manu'a vave. Afai e manifinifi tele le uu, atonu e le aoga.
#Polysporin
#Bacitracin
#Betadine
Fa'aaogā fa'ama'i tiga ole OTC pei ole acetaminophen e fa'amama ai le tiga.
#Ibuprofen
#Naproxen
#Acetaminophen
Tausia vae mama ma togafitia le vae o le tagata taʻalo aua o le vae o le tagata taʻalo e faʻateleina le lamatiaga o le cellulitis.
○ Togafitiga
#First-generation cephalosporins (e.g. Cefradine)
#Bacterial culture
#Third-generation cephalosporins (e.g. Cefditoren Pivoxil)